Las Vegas, NV -- (SBWIRE) -- 10/23/2013 -- Value Stock Pick is a leading Investment Newsletter. Our Research Team conducts research on different stocks, doing their due diligence to provide a detailed report, including both technical and fundamental analysis, on NYSE, NASDAQ, AMEX, OTCBB and Pink Sheet Stocks. Let’s have a brief look at: The Wendy's Co (NASDAQ:WEN), Sequenom, Inc. (NASDAQ:SQNM), Pain Therapeutics, Inc. (NASDAQ:PTIE), Depomed Inc (NASDAQ:DEPO).
The Wendy's Co (NASDAQ:WEN) ended its recent business day with the tumbled of -0.46% and closed at the price of $8.60 after opening at $8.65. The stock traded during its last trading session with the total volume of 3.34 million shares, as compared to its average volume of 6.58 million shares. The Wendy’s Company, through its subsidiaries, owns and franchises Wendy’s restaurant system in North America and internationally.
Will WEN Get Buyers Even After The Recent Rally? Find Out Here
Sequenom, Inc. (NASDAQ:SQNM) remained among the day bearish and traded with volume of 3.18 million shares in the last session, as compared to average volume of 2.78 million shares. In comparison with 52 week range of $2.26 - $5.36, it faced lowest price of $2.26 during the last trading session whereas its day highest price was $2.41. The company’s total market capitalization is $266.49 million, along with 115.36 million shares outstanding. Sequenom, Inc., a life sciences company, provides genetic analysis solutions in the United States and internationally.
Will SQNM Get Buyers Even After The Recent Rally? Find Out Here
Pain Therapeutics, Inc. (NASDAQ:PTIE) showed 3.15 million shares in volume during the last trading session, while the average trading volume remained 202.237 shares. The stock kicked off its trading session at $4.24 and closed at $3.77 after rallied 16.00%. Pain Therapeutics, Inc., a biopharmaceutical company, develops novel drugs. Its lead drug candidate is REMOXY (oxycodone) Extended-Release Capsules CII, an investigational drug with a controlled release formulation of oxycodone for patients with moderate-to-severe chronic pain.
Will PTIE Continue To Move Higher? Find Out Here
Depomed Inc (NASDAQ:DEPO) stock traded during its last trading session with the total traded volume of 3.07 million shares versus its average volume of 301.536 shares. The company opened its trade at the price of $8.00 and its closing price was $7.67 after gained 6.09% for the day. Depomed, Inc., a specialty pharmaceutical company, focuses on developing products for pain and other conditions, and diseases of the central nervous system in the United States.
Will DEPO Continue To Move Higher? Find Out Here
PLEASE NOTE WELL: The employees of ValueStockPick.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site, Press releases or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Please Read Our Full Disclaimer at http://www.valuestockpick.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)